HAVCR2 and glioma: In the murine glioma model studies, the upregulation of TIM3 in PD-1 antibody bound T cells was reported after failure of PD-1 blockade treatment [91] and the increase in exhausted PD-1 + TIM3 + T cells was observed in a time-dependent manner with tumor progression [92].